Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed

• Hoofdauteurs: Guillaume Le Guyader (Auteur), Bernard Do (Auteur), Victoire Vieillard (Auteur), Karine Andrieux (Auteur), Muriel Paul (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2020-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Rapamycin has been used topically to treat facial angiofibromas associated with tuberous sclerosis for more than a decade. In the absence of a commercial form, a large number of formulations have been clinically tested. However, given the great heterogeneity of these studies, particularly with regar...